Dextran-Polyacrylamide as Matrices for Creation of Anticancer Nanocomposite

Figure 6

Histograms of distribution of U937 cells in content of DNA with the influence of cisplatin in solution or in conjunction with dextran containing nanoparticles: (a) control; (b) cisplatin solution of 3 μmol/L; (c) nanocontainers loaded with cytotoxic chemotherapy drugs cisplatin, 3 μmol/L.

(a)

(b)

(c)